Claret Asset Management Corp
Position in INDV — Indivior Pharmaceuticals, Inc.
CIK 1735513
MONTREAL, A8
Position in INDV
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$28,127,008
+$6,569,510 QoQ
Shares Held
685,523
-3.1% QoQ
Ownership
0.581%
of shares outstanding
% of Portfolio
3.13%
of 13F equity value
Holder Rank
#41
of 334 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INDV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Claret Asset Management Corp holds $30,317,140 across 7 Drug Manufacturers - Specialty & Generic names. INDV ranks #1 (92.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
685,523 | $28,127,008 | |
| 2 | BHC |
Bausch Health Companies Inc.
|
204,108 | $1,006,252 | |
| 3 | ZTS |
Zoetis Inc.
|
3,526 | $253,378 | |
| 4 | VTRS |
Viatris Inc
|
15,214 | $241,598 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
1,425 | $240,169 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
9,119 | $224,418 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
414 | $224,317 |
All Filings in INDV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,127,008 | 685,523 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $21,557,498 | 707,267 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||